Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials. / Maraldo, Maja V.; Giusti, Francesco; Vogelius, Ivan R.; Jensen, Michael Lundemann; van der Kaaij, Marleen A. E.; Ramadan, Safaa; Meulemans, Bart; Henry-Amar, Michel; Aleman, Berthe M. P.; Raemaekers, John; Meijnders, Paul; Moser, Elisabeth C.; Kluin-Nelemans, Hanneke C.; Feugier, Pierre; Casasnovas, Olivier; Fortpied, Catherine; Specht, Lena.

In: Lancet Haematology, Vol. 2, No. 11, 01.11.2015, p. E492-E502.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Maraldo, MV, Giusti, F, Vogelius, IR, Jensen, ML, van der Kaaij, MAE, Ramadan, S, Meulemans, B, Henry-Amar, M, Aleman, BMP, Raemaekers, J, Meijnders, P, Moser, EC, Kluin-Nelemans, HC, Feugier, P, Casasnovas, O, Fortpied, C & Specht, L 2015, 'Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials', Lancet Haematology, vol. 2, no. 11, pp. E492-E502. https://doi.org/10.1016/S2352-3026(15)00153-2

APA

Maraldo, M. V., Giusti, F., Vogelius, I. R., Jensen, M. L., van der Kaaij, M. A. E., Ramadan, S., Meulemans, B., Henry-Amar, M., Aleman, B. M. P., Raemaekers, J., Meijnders, P., Moser, E. C., Kluin-Nelemans, H. C., Feugier, P., Casasnovas, O., Fortpied, C., & Specht, L. (2015). Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials. Lancet Haematology, 2(11), E492-E502. https://doi.org/10.1016/S2352-3026(15)00153-2

Vancouver

Maraldo MV, Giusti F, Vogelius IR, Jensen ML, van der Kaaij MAE, Ramadan S et al. Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials. Lancet Haematology. 2015 Nov 1;2(11):E492-E502. https://doi.org/10.1016/S2352-3026(15)00153-2

Author

Maraldo, Maja V. ; Giusti, Francesco ; Vogelius, Ivan R. ; Jensen, Michael Lundemann ; van der Kaaij, Marleen A. E. ; Ramadan, Safaa ; Meulemans, Bart ; Henry-Amar, Michel ; Aleman, Berthe M. P. ; Raemaekers, John ; Meijnders, Paul ; Moser, Elisabeth C. ; Kluin-Nelemans, Hanneke C. ; Feugier, Pierre ; Casasnovas, Olivier ; Fortpied, Catherine ; Specht, Lena. / Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials. In: Lancet Haematology. 2015 ; Vol. 2, No. 11. pp. E492-E502.

Bibtex

@article{82eb1c375bf24906b1ca5d5bebace422,
title = "Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials",
author = "Maraldo, {Maja V.} and Francesco Giusti and Vogelius, {Ivan R.} and Jensen, {Michael Lundemann} and {van der Kaaij}, {Marleen A. E.} and Safaa Ramadan and Bart Meulemans and Michel Henry-Amar and Aleman, {Berthe M. P.} and John Raemaekers and Paul Meijnders and Moser, {Elisabeth C.} and Kluin-Nelemans, {Hanneke C.} and Pierre Feugier and Olivier Casasnovas and Catherine Fortpied and Lena Specht",
year = "2015",
month = nov,
day = "1",
doi = "10.1016/S2352-3026(15)00153-2",
language = "English",
volume = "2",
pages = "E492--E502",
journal = "The Lancet Haematology",
issn = "2352-3026",
publisher = "The Lancet Publishing Group",
number = "11",

}

RIS

TY - JOUR

T1 - Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials

AU - Maraldo, Maja V.

AU - Giusti, Francesco

AU - Vogelius, Ivan R.

AU - Jensen, Michael Lundemann

AU - van der Kaaij, Marleen A. E.

AU - Ramadan, Safaa

AU - Meulemans, Bart

AU - Henry-Amar, Michel

AU - Aleman, Berthe M. P.

AU - Raemaekers, John

AU - Meijnders, Paul

AU - Moser, Elisabeth C.

AU - Kluin-Nelemans, Hanneke C.

AU - Feugier, Pierre

AU - Casasnovas, Olivier

AU - Fortpied, Catherine

AU - Specht, Lena

PY - 2015/11/1

Y1 - 2015/11/1

U2 - 10.1016/S2352-3026(15)00153-2

DO - 10.1016/S2352-3026(15)00153-2

M3 - Journal article

VL - 2

SP - E492-E502

JO - The Lancet Haematology

JF - The Lancet Haematology

SN - 2352-3026

IS - 11

ER -

ID: 153105384